✦ LIBER ✦

Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer

✍ Scribed by Valentina Guarneri; Annarita Pecchi; Federico Piacentini; Elena Barbieri; Maria Vittoria Dieci; Guido Ficarra; Giovanni Tazzioli; Antonio Frassoldati; Rachele Battista; Barbara Canossi; Claudia Mauri; Roberto D’Amico; PierFranco Conte; Pietro Torricelli

Book ID: 111774076
Publisher: Springer
Year: 2011
Tongue: English
Weight: 291 KB
Volume: 18
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-011-1590-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Magnetic Resonance Imaging and Ultrasono

Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer

✍ Amodei, L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Preoperative Evaluation of Residual Tumo

Preoperative Evaluation of Residual Tumor Extent by Three-Dimensional Magnetic Resonance Imaging in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

✍ Kenji Akazawa; Yasuhiro Tamaki; Tetsuya Taguchi; Yoshio Tanji; Yasuo Miyoshi; Se 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

The role of magnetic resonance imaging i

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

✍ M. B. I. Lobbes, R. Prevos, M. Smidt, V. C. G. Tjan-Heijnen… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 265 KB

Accuracy of magnetic resonance imaging i

Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : Correlation of Radiologic Findings With Surgicopathologic Results

✍ Etienne Vincens; Corinne Balleyguier; Annie Rey; Catherine Uzan; Elise Zareski; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract ## BACKGROUND The evaluation of residual disease (RD) after chemoradiation therapy (CRT) in stage IB2/II cervical carcinoma conventionally is based on a clinical examination and magnetic resonance imaging (MRI) performed 3 to 8 weeks after the end of treatment. Very few studies have co